Samy Suissa

Director of the Centre of Clinical Epidemiology
McGill University, Quebec, Canada

Atarabio (Consultant/Advisory Board)Boehringer-Ingelheim (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Merck (Consultant/Advisory Board)Novartis (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Panalgo (Consultant/Advisory Board)Pfizer (Consultant/Advisory Board)Sequiris (Consultant/Advisory Board)

Presentation(s):

• Incretin-based Drugs and the Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Among Patients with Type 2 Diabetes

  Friday, August 26, 2022
  1:30 PM – 1:45 PM CEST